Current therapeutic strategies for multiple myeloma.

Current therapeutic strategies for multiple myeloma.

Item
http://www.wikidata.org/entity/Q38412189
Computational Approaches for the Discovery of Human Proteasome Inhibitors: An OverviewEfficacy and Safety of Panobinostat in Relapsed or/and Refractory Multiple Myeloma: Meta Analyses of Clinical Trials and Systematic Review.Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo.Multiple myeloma: patient outcomes in real-world practice.Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma.Transcription factor IKZF1 is degraded during the apoptosis of multiple myeloma cells induced by kinase inhibition.Multiple myeloma: practice patterns across Europe.Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue.Immunoproteasome inhibition and bioactivity of thiasyrbactins.Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance.Chart review across EU5 in MM post-ASCT patients
P2860

Current therapeutic strategies for multiple myeloma.

Item
http://www.wikidata.org/entity/Q38412189
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Current therapeutic strategies for multiple myeloma.
@en
type
label
Current therapeutic strategies for multiple myeloma.
@en
prefLabel
Current therapeutic strategies for multiple myeloma.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Current therapeutic strategies for multiple myeloma.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698